Recent studies have reported that C225, an anti-epidermal growth factor receptor (EGFR) monoclonal antibody, can, in combination with radiation, suppress STAT3 activation results in radiosensitization in head and neck cancer [12]. Here, STAT3 is linked to head and neck cancer.